Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
Year: 2012
Type: article
Study design: Clinical Trial
Authors: Prithviraj Bose, Edward B. Perkins, Connie Honeycut, Martha D. Wellons, Tammy Stefan, James W. Jacobberger, Emmanouil Kontopodis, Jan H. Beumer, Merrill J. Egorin, Chiyo K. Imamura, W. Douglas Figg, Judith E. Karp, Omer N. Koc, Brenda W. Cooper, Selina M. Luger, A. Dimitrios Colevas, John D. Roberts, Steven Grant
Institutions: Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University Medical Center, Case Comprehensive Cancer Center, Case Western Reserve University, UPMC Hillman Cancer Center, University Hospital of Heraklion, University of Pittsburgh, Keio University, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Cleveland Clinic, University of Pennsylvania, Stanford Medicine, Stanford University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1016094800, G1097778143, G131572022, G1353051725, G1357033417, G146968441, Phase I Clinical Trials of New Anti-Cancer Targeted Therapies, G3148123924, G3518617075, G424558205, G5240870613, General Clinical Research Center, G6546624264, G741073515, G884243897, Massey Cancer Center - Cancer Center Support Grant
OpenAlex ID: W2015859997